.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Medtronic
Cantor Fitzgerald
Fish and Richardson
Citi
Baxter
US Army
Johnson and Johnson
Harvard Business School

Generated: June 24, 2017

DrugPatentWatch Database Preview

ROXICODONE Drug Profile

« Back to Dashboard

Which patents cover Roxicodone, and what generic Roxicodone alternatives are available?

Roxicodone is a drug marketed by Mallinckrodt Inc and Roxane and is included in two NDAs.

The generic ingredient in ROXICODONE is oxycodone hydrochloride. There are seventeen drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.

Summary for Tradename: ROXICODONE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list13
Clinical Trials: see list9
Patent Applications: see list5,358
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ROXICODONE at DailyMed

Pharmacology for Tradename: ROXICODONE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt Inc
ROXICODONE
oxycodone hydrochloride
TABLET;ORAL021011-003May 15, 2009ABRXYesNo► Subscribe► Subscribe
Roxane
ROXICODONE
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL020932-001Oct 26, 1998DISCNNoNo► Subscribe► Subscribe
Mallinckrodt Inc
ROXICODONE
oxycodone hydrochloride
TABLET;ORAL021011-001Aug 31, 2000ABRXYesYes► Subscribe► Subscribe
Mallinckrodt Inc
ROXICODONE
oxycodone hydrochloride
TABLET;ORAL021011-002Aug 31, 2000ABRXYesNo► Subscribe► Subscribe
Roxane
ROXICODONE
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL020932-002Oct 26, 1998DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Moodys
Chubb
Healthtrust
Farmers Insurance
QuintilesIMS
Cipla
Fish and Richardson
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot